These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37151875)
1. CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway. Chan S; Wang X; Wang Z; Du Y; Zuo X; Chen J; Sun R; Zhang Q; Lin L; Yang Y; Yu Z; Zhao H; Zhang H; Chen W Int J Biol Sci; 2023; 19(7):2220-2233. PubMed ID: 37151875 [TBL] [Abstract][Full Text] [Related]
2. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
3. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway. Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839 [TBL] [Abstract][Full Text] [Related]
4. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway. Li Y; Peng F; Tan X; Wang J; Xu Y Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976 [TBL] [Abstract][Full Text] [Related]
6. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling. Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457 [TBL] [Abstract][Full Text] [Related]
7. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway. Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121 [TBL] [Abstract][Full Text] [Related]
8. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells. Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218 [TBL] [Abstract][Full Text] [Related]
9. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade. Tang B; Zhu J; Liu F; Ding J; Wang Y; Fang S; Zheng L; Qiu R; Chen M; Shu G; Xu M; Lu C; Zhao Z; Yang Y; Ji J Cell Death Dis; 2022 Apr; 13(4):373. PubMed ID: 35440604 [TBL] [Abstract][Full Text] [Related]
10. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148 [TBL] [Abstract][Full Text] [Related]
11. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors. Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M Cells; 2020 Sep; 9(9):. PubMed ID: 32962206 [TBL] [Abstract][Full Text] [Related]
12. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Weng ML; Chen WK; Chen XY; Lu H; Sun ZR; Yu Q; Sun PF; Xu YJ; Zhu MM; Jiang N; Zhang J; Zhang JP; Song YL; Ma D; Zhang XP; Miao CH Nat Commun; 2020 Apr; 11(1):1869. PubMed ID: 32313017 [TBL] [Abstract][Full Text] [Related]
13. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway. Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932 [TBL] [Abstract][Full Text] [Related]
14. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway. Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562 [TBL] [Abstract][Full Text] [Related]
15. A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca Wang C; Chen J; Kuang Y; Cheng X; Deng M; Jiang Z; Hu X Int J Biol Sci; 2022; 18(14):5575-5590. PubMed ID: 36147460 [TBL] [Abstract][Full Text] [Related]
16. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p. Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664 [TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling. Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439 [TBL] [Abstract][Full Text] [Related]
18. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
19. Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway. Tian Y; Shen L; Li F; Yang J; Wan X; Ouyang M J Cell Physiol; 2020 Jan; 235(1):442-453. PubMed ID: 31332784 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway. Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]